Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of NT 201 for chronic troublesome sialorrhea in adults with neurological disorders
2012-005539-10Phase 3Completed
- Sponsor
- Merz
- Start
- Dec 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of botulinum toxin type A in hypersalivation (3 arms), sponsored by Merz. Primary endpoints: Unstimulated salivary flow rate and Global Impression of Change Scale. Started Dec 2013; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
hypersalivation
Beyond the preview
Go deeper on 2012-005539-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005539-10.